The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) therapy have an increased risk of developing cognitive impairment and dementia, which are known relevant factors in disease prognosis and therapeutic success, but still lack adequate screening in clinical routine. We evaluated the Mo...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4209968?pdf=render |
| _version_ | 1818924929185218560 |
|---|---|
| author | Frances E Tiffin-Richards Ana S Costa Bernhard Holschbach Rolf D Frank Athina Vassiliadou Thilo Krüger Karl Kuckuck Theresa Gross Frank Eitner Jürgen Floege Jörg B Schulz Kathrin Reetz |
| author_facet | Frances E Tiffin-Richards Ana S Costa Bernhard Holschbach Rolf D Frank Athina Vassiliadou Thilo Krüger Karl Kuckuck Theresa Gross Frank Eitner Jürgen Floege Jörg B Schulz Kathrin Reetz |
| author_sort | Frances E Tiffin-Richards |
| collection | DOAJ |
| description | Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) therapy have an increased risk of developing cognitive impairment and dementia, which are known relevant factors in disease prognosis and therapeutic success, but still lack adequate screening in clinical routine. We evaluated the Montreal Cognitive Assessment (MoCA) for suitability in assessing cognitive performance in HD patients in comparison to the commonly used Mini-Mental State Examination (MMSE) and a detailed neuropsychological test battery, used as gold standard.43 HD patients and 42 healthy controls with an average age of 58 years, were assessed with the MoCA, the MMSE and a detailed neuropsychological test battery, covering the domains of memory, attention, language, visuospatial and executive functions. Composite scores were created for comparison of cognitive domains and test results were analyzed using Spearman's correlation and linear regression. Cognitive dysfunction was defined using z-score values and predictive values were calculated. Sensitivity and specificity of the MoCA were determined using receiver operating characteristic (ROC) analysis.HD patients performed worse in all cognitive domains, especially in memory recall and executive functions. The MoCA correlated well with the detailed test battery and identified patients with cognitive impairment with a sensitivity of 76.7% and specificity of 78.6% for a cut-off value of ≤24 out of 30 points. In the detailed assessment executive functions accounted significantly for performance in the MoCA. The MMSE only discriminated weakly between groups.The MoCA represents a suitable cognitive screening tool for hemodialysis patients, demonstrating good sensitivity and specificity levels, and covering executive functions, which appear to play an important role in cognitive performance of HD patients. |
| first_indexed | 2024-12-20T02:33:08Z |
| format | Article |
| id | doaj.art-4cad84fd4af843d8b42c0b625dd8aab3 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T02:33:08Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-4cad84fd4af843d8b42c0b625dd8aab32022-12-21T19:56:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10670010.1371/journal.pone.0106700The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.Frances E Tiffin-RichardsAna S CostaBernhard HolschbachRolf D FrankAthina VassiliadouThilo KrügerKarl KuckuckTheresa GrossFrank EitnerJürgen FloegeJörg B SchulzKathrin ReetzChronic kidney disease (CKD) patients undergoing hemodialysis (HD) therapy have an increased risk of developing cognitive impairment and dementia, which are known relevant factors in disease prognosis and therapeutic success, but still lack adequate screening in clinical routine. We evaluated the Montreal Cognitive Assessment (MoCA) for suitability in assessing cognitive performance in HD patients in comparison to the commonly used Mini-Mental State Examination (MMSE) and a detailed neuropsychological test battery, used as gold standard.43 HD patients and 42 healthy controls with an average age of 58 years, were assessed with the MoCA, the MMSE and a detailed neuropsychological test battery, covering the domains of memory, attention, language, visuospatial and executive functions. Composite scores were created for comparison of cognitive domains and test results were analyzed using Spearman's correlation and linear regression. Cognitive dysfunction was defined using z-score values and predictive values were calculated. Sensitivity and specificity of the MoCA were determined using receiver operating characteristic (ROC) analysis.HD patients performed worse in all cognitive domains, especially in memory recall and executive functions. The MoCA correlated well with the detailed test battery and identified patients with cognitive impairment with a sensitivity of 76.7% and specificity of 78.6% for a cut-off value of ≤24 out of 30 points. In the detailed assessment executive functions accounted significantly for performance in the MoCA. The MMSE only discriminated weakly between groups.The MoCA represents a suitable cognitive screening tool for hemodialysis patients, demonstrating good sensitivity and specificity levels, and covering executive functions, which appear to play an important role in cognitive performance of HD patients.http://europepmc.org/articles/PMC4209968?pdf=render |
| spellingShingle | Frances E Tiffin-Richards Ana S Costa Bernhard Holschbach Rolf D Frank Athina Vassiliadou Thilo Krüger Karl Kuckuck Theresa Gross Frank Eitner Jürgen Floege Jörg B Schulz Kathrin Reetz The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS ONE |
| title | The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. |
| title_full | The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. |
| title_fullStr | The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. |
| title_full_unstemmed | The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. |
| title_short | The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. |
| title_sort | montreal cognitive assessment moca a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients |
| url | http://europepmc.org/articles/PMC4209968?pdf=render |
| work_keys_str_mv | AT francesetiffinrichards themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT anascosta themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT bernhardholschbach themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT rolfdfrank themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT athinavassiliadou themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT thilokruger themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT karlkuckuck themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT theresagross themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT frankeitner themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT jurgenfloege themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT jorgbschulz themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT kathrinreetz themontrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT francesetiffinrichards montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT anascosta montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT bernhardholschbach montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT rolfdfrank montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT athinavassiliadou montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT thilokruger montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT karlkuckuck montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT theresagross montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT frankeitner montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT jurgenfloege montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT jorgbschulz montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients AT kathrinreetz montrealcognitiveassessmentmocaasensitivescreeninginstrumentfordetectingcognitiveimpairmentinchronichemodialysispatients |